Abstract:
Provided are conformable light delivery devices for increasing light penetration depth and related methods. The device comprises a tissue penetrating member having a distal end and a proximal end, the tissue penetrating member configured to penetrate the tissue of the patient to be inserted into the tissue, wherein the tissue penetrating member is at least partially optically transparent along a surface of the tissue penetrating member positioned between the distal end of the tissue penetrating member and the proximal end of the tissue penetrating member to provide optical transmission of at least a portion of the light through the surface of the tissue penetrating member, thereby allowing at least the portion of the light to be delivered into the tissue of the patient when the tissue penetrating member is inserted into the tissue; and a substrate that supports the tissue penetrating member.
Abstract:
An apparatus includes a catheter including light fibers extending from a proximal section to a distal section. The apparatus may include an emission section positioned on the distal section that is coated with an NVS agent. The material of the emission section may be different from the other sections of the catheter. The apparatus can be sterilized using E-beam sterilization.
Abstract:
A therapeutic illumination assembly includes a catheter and a point source treatment fiber. The catheter comprises a catheter wall encircling a luminal fluid pathway. The point source treatment fiber is positioned within the luminal fluid pathway of the catheter. Further, the point source treatment fiber comprises a plurality of light emitting point sources intermittently positioned along a treatment length of the point source treatment fiber such that the plurality of light emitting point sources irradiate the catheter when the plurality of light emitting point sources emit light.
Abstract:
Naphthalimide compounds as used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bone tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabilization of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.
Abstract:
The present application is directed to devices, assemblies, systems and methods for targeting one or more sites with electromagnetic radiation. The devices, assemblies and systems are operationally configured to transform and convey electromagnetic radiation to one or more targeted sites. The devices, assemblies and systems may also convey one or more fluids or fluid solutions to the one or more targeted sites.
Abstract:
An apparatus for efficient delivery of light to a target site in a human body wherein the apparatus includes a light source and at least one stent having a lumen defined longitudinally therethrough. The light source is disposed longitudinally within the lumen of the stent and/or on a surface of the stent. Also, a method for efficient delivery of phototherapy to the brain in the human body. A hole is drilled in the skull without penetrating dura matter in the brain. Each drilled hole is fitted with a transparent light conductor so that each light conductor fully penetrates the skull. Light emitted from a light source disposed on a first side exteriorly of the skull is transmitted through to an opposite side interiorly of the skull to a target site within the brain via the transparent light conductor.
Abstract:
A method for inducing thrombosis in an artery of a living animal includes: implanting an implantable medical device into a living animal, the implantable medical device including a light-emitting element and a wireless power receiver; administrating a photo-sensitizing dye material into the living animal; and providing wirelessly a control signal, from an external power controller, to the wireless power receiver which transmits electrical power to the light-emitting element in response to the control signal to drive the light-emitting element to emit light for irradiating the artery of the living animal.
Abstract:
A laser light irradiation device is disclosed, which can include an optical guide having a columnar portion and transmitting laser light through the columnar portion; a reflecting portion having a reflecting surface that reflects the laser light transmitted through the optical guide; and a transmitting portion having a window part and disposed between the columnar portion of the optical guide and the reflecting portion in such a manner that one end of the transmitting portion is in contact with the columnar portion, the transmitting portion transmitting the laser light emitted from the columnar portion to the reflecting portion and transmitting the laser light reflected by the reflecting surface to cause the laser light to be radiated to an external through the window part. A diameter of the reflecting surface gradually becomes smaller as distance from a boundary between the transmitting portion and the reflecting portion increases.
Abstract:
In response to local or systemic inflammation in a patient, photobiomodulation therapy is applied to a cardiac location to reduce the risk and/or occurrence of cardiac arrhythmia. Once inflammation is identified, photobiomodulation therapy can be applied in any suitable fashion (e.g., via a catheter- or transesophageal probe-mounted photoemitter, via an externally-applied photoemitter, or via photoemitter incorporated into an implantable medical device). Photobiomodulation therapy can also be employed to good advantage in conjunction with non-photobiomodulation therapy (e.g., traditional cardiac rhythm management therapies).
Abstract:
The present application is directed to devices, assemblies, systems and methods for targeting one or more sites with electromagnetic radiation. The devices, assemblies and systems are operationally configured to transform and convey electromagnetic radiation to one or more targeted sites. The devices, assemblies and systems may also convey one or more fluids or fluid solutions to the one or more targeted sites.